BrainDTech is Diagnostic Equipment in Italy that focus on neurodegenerative disease business. Founded in 2016. They cover business area such as provider, neurodegenerative disease diagnostic system, early detection, brain disease, liquid biopsy, diagnosis, prognosis, treatment monitoring, neurodegenerative, neurological and inflammatory disease, miRNA, microglia microvesicle, doctor, symptom.
2016
( 8 years old in 2024 )
Neurodegenerative Disease
-
Via Ludovico Ariosto, 21
20091 Bresso(Milan)
Italy
Private
providerneurodegenerative disease diagnostic systemearly detectionbrain diseaseliquid biopsydiagnosisprognosistreatment monitoringneurodegenerative, neurological and inflammatory diseasemiRNAmicroglia microvesicledoctorsymptom
* We use standard office opening hours in near BrainDTech's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
BrainDTech is Diagnostic Equipment business from Italy that founded in 2016 (8 years old in 2024), BrainDTech business is focusing on Neurodegenerative Disease.
BrainDTech headquarter office and corporate office address is located in Via Ludovico Ariosto, 21 20091 Bresso(Milan) Italy.
BrainDTech was founded in Italy.
In 2024, BrainDTech is currently focus on neurodegenerative disease sector.
Above is snippet of Google Trends for "neurodegenerative disease" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with BrainDTech, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.